The National Organization for Rare Disorders (NORD) is seeking participants for its survey-based study Living Rare, which aims to…
Articles by Lindsey Shapiro, PhD
FT011, Certa Therapeutics’ oral treatment candidate for systemic sclerosis (SSc), will now be known under the generic name…
Ferroptosis, a cell death process that can help to regulate uncontrolled cell growth, was suppressed in skin cells from people…
Researchers have developed a model for predicting which systemic sclerosis (SSc) patients with interstitial lung disease (ILD) —…
A non-invasive technique called flow-mediated dilation (FMD) could be useful for monitoring blood vessel alterations in people with systemic…
Antibodies designed to neutralize the protein galectin-3 (Gal-3) eased scarring and inflammation in a mouse model of systemic sclerosis…
Aisa Pharma has launched the second part of its Phase 2a trial evaluating Profervia (cilnidipine) — an oral medication…
Certain metabolic changes in the blood could serve as biomarkers for systemic sclerosis (SSc), according to a recent analysis.
An analysis of genetic data from patient skin samples revealed four genes that may be involved in the development or…
The National Scleroderma Foundation has awarded a $200,000 research grant to a University of Minnesota scientist to study how…